Kiniksa Pharmaceuticals International annual net profit margin
2021
2022
2023
2024
2025
Kiniksa Pharmaceuticals International Net Profit Margin Growth & History (KNSA)
Kiniksa Pharmaceuticals International's net profit margin was 8.71% for fiscal 2025.
View full Kiniksa Pharmaceuticals International company overviewKiniksa Pharmaceuticals International annual net profit margin history
| Fiscal year | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 8.71% | +18.91 pp |
| 2024 | 2024-12-31 | −10.21% | −15.42 pp |
| 2023 | 2023-12-31 | 5.21% | −78.07 pp |
| 2022 | 2022-12-31 | 83.28% | +493.00 pp |
| 2021 | 2021-12-31 | −409.72% | — |
Kiniksa Pharmaceuticals International quarterly net profit margin
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 10.44% | −0.93 pp |
| Q1 2026 | 2026-03-31 | 10.54% | +4.35 pp |
| Q4 2025 | 2025-12-31 | 7.02% | +14.28 pp |
| Q3 2025 | 2025-09-30 | 10.19% | +21.50 pp |
| Q2 2025 | 2025-06-30 | 11.37% | +14.97 pp |
| Q1 2025 | 2025-03-31 | 6.20% | +28.37 pp |
| Q4 2024 | 2024-12-31 | −7.25% | −37.52 pp |
| Q3 2024 | 2024-09-30 | −11.31% | +9.35 pp |
| Q2 2024 | 2024-06-30 | −3.60% | −24.55 pp |
| Q1 2024 | 2024-03-31 | −22.17% | +3.21 pp |
| Q4 2023 | 2023-12-31 | 30.26% | +23.05 pp |
| Q3 2023 | 2023-09-30 | −20.66% | −246.71 pp |
| Q2 2023 | 2023-06-30 | 20.95% | +95.03 pp |
| Q1 2023 | 2023-03-31 | −25.38% | +52.94 pp |
| Q4 2022 | 2022-12-31 | 7.21% | — |
| Q3 2022 | 2022-09-30 | 226.05% | +478.58 pp |
| Q2 2022 | 2022-06-30 | −74.08% | +465.42 pp |
| Q1 2022 | 2022-03-31 | −78.32% | — |
| Q3 2021 | 2021-09-30 | −252.53% | — |
| Q2 2021 | 2021-06-30 | −539.50% | — |
Kiniksa Pharmaceuticals International net profit margin trends
Between the periods ended 2021-12-31 and 2025-12-31, Kiniksa Pharmaceuticals International's net profit margin increased from −409.72% to 8.71%, a change of +418.43 percentage points. The latest reported quarter, Q2 2026, shows 10.44%.
About the metric
What net profit margin means
Net profit margin measures the percentage of revenue remaining as net income after operating costs, interest, taxes, and other expenses. It shows how much bottom-line profit or loss a company generates from each dollar of revenue.
Calculation and source
How net profit margin is calculated
TickerStat calculates net profit margin as SEC-reported net income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Kiniksa Pharmaceuticals International source filings ↗